Buhlmann fCAL turbo and CALEX Cap— 510(k) K191718

Substantially Equivalent

Buhlmann Laboratories AG

FDA 510(k) clearance K191718 for Buhlmann fCAL turbo and CALEX Cap, Substantially Equivalent on 2019-09-24. Applicant: Buhlmann Laboratories AG.

Clearance details

Applicant: Buhlmann Laboratories AG
Product code: Code NXO
Advisory panel: Immunology
Date received: 2019-06-26
Decision date: 2019-09-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Schönenbuch, CH

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.